These common health issues may increase brain damage in COVID-19
The virus that causes COVID-19 first attacks cells in the respiratory system, often leading to an inflammation of the lungs that puts people at...
This drug may improve survival in people with diabetes and COVID-19
Sitagliptin, an oral drug, is prescribed to 15% to 20% of patients with type 2 diabetes.
It was approved by the FDA in 2006 and...
How to improve your well-being in the COVID-19 pandemic
Have you been feeling more stressed than usual?
Many people are during these challenging times. The COVID-19 pandemic has many people feeling overwhelmed.
Everyone feels stress...
How smoking worsens COVID-19 infection
In a new study, researchers found how smoking cigarettes causes more severe infection by SARS-CoV-2, the virus that causes COVID-19, in the airways of...
Scientists find effective ways to detect brain injury in people with COVID-19
COVID-19 can directly cause neurologic symptoms and long-term neurological disease.
Elevations of blood biomarkers indicative of brain injury have been reported in the blood of...
Infectiousness peaks early in people with COVID-19, study finds
In a new study, researchers found that no live virus (that can cause infection) was found in any type of sample collected beyond nine...
10 expert COVID-19 tips to follow in 2021
While the world waves ta-ta to 2020 and looks forward to 2021, a lot of advice and information from doctors and researchers you’ve learned...
Common gut inflammation linked to COVID-19, study finds
In a new study, researchers found An enzyme that helps COVID-19 (coronavirus) infect the body also plays a role in inflammation and patient outcomes...
Scientists find blood vessel damage and inflammation in COVID-19 patients’ brains
In a new study, researchers found examined how COVID-19 affects a patient’s brain.
They found hallmarks of damage caused by thinning and leaky brain blood...
This anti-inflammatory drug could reduce COVID-19 death risk
In a recent study, researchers examined the effects of the anti-inflammatory drug tocilizumab on critically ill patients with laboratory-confirmed COVID-19.
Unlike steroids, which suppress the...